共 50 条
- [41] Biologic variability of response to glycoprotein IIb/IIIa platelet inhibitors supports in-laboratory rapid platelet function assay to optimize platelet inhibition during percutaneous coronary intervention. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 97G - 97G
- [45] Meta-Analysis of Randomized Controlled Trials of Intracoronary Versus Intravenous Administration of Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention for Acute Coronary Syndrome AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (09): : 1244 - 1251
- [46] IMMEDIATE AND REVERSIBLE PLATELET INHIBITION AFTER INTRAVENOUS ADMINISTRATION OF A PEPTIDE GLYCOPROTEIN IIB/IIIA INHIBITOR DURING PERCUTANEOUS CORONARY INTERVENTION AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (17): : 1222 - 1227
- [48] Clopidogrel and glycoprotein IIb/IIIa inhibitors: Effect on adenosine diphosphate-induced platelet aggregation during coronary interventions. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 99G - 99G
- [49] Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization - Management strategies for the cardiac surgeon JOURNAL OF CARDIOVASCULAR SURGERY, 1999, 40 (04): : 505 - 516